Loading…

Synthesis and Evaluation of [N-methyl-11C]N-Desmethyl-loperamide as a New and Improved PET Radiotracer for Imaging P-gp Function

[11C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [N-methyl-11C]N-desmethyl-loperamide ([11C]dLop; [11C]3) precludes quantification. We considered that [11C]3 might itself be a superior radiotracer for imaging...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2008-10, Vol.51 (19), p.6034-6043
Main Authors: Lazarova, Neva, Zoghbi, Sami S, Hong, Jinsoo, Seneca, Nicholas, Tuan, Ed, Gladding, Robert L, Liow, Jeih-San, Taku, Andrew, Innis, Robert B, Pike, Victor W
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[11C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [N-methyl-11C]N-desmethyl-loperamide ([11C]dLop; [11C]3) precludes quantification. We considered that [11C]3 might itself be a superior radiotracer for imaging brain P-gp function and therefore aimed to prepare [11C]3 and characterize its efficacy. An amide precursor (2) was synthesized and methylated with [11C]iodomethane to give [11C]3. After administration of [11C]3 to wild-type mice, brain radioactivity uptake was very low. In P-gp (mdr-1a(−/−)) knockout mice, brain uptake of radioactivity at 30 min increased about 3.5-fold by PET measures, and over 7-fold by ex vivo measures. In knockout mice, brain radioactivity was predominantly (90%) unchanged radiotracer. In monkey PET experiments, brain radioactivity uptake was also very low but after P-gp blockade increased more than 7-fold. [11C]3 is an effective new radiotracer for imaging brain P-gp function and, in favor of future successful quantification, appears free of extensive brain-penetrant radiometabolites.
ISSN:0022-2623
1520-4804
DOI:10.1021/jm800510m